SHM Joins Multi-Stakeholder Letter Supporting the MAT Act
SHM joins over 100 medical societies and patient advocacy groups supporting the inclusion of the "Mainstreaming Addiction Treatment Act" to the broader "Restoring Hope for Mental Health
Your Browser Is No Longer Supported. Please upgrade your browser from Internet Explorer 10 to Internet Explorer 11 or higher
SHM joins over 100 medical societies and patient advocacy groups supporting the inclusion of the "Mainstreaming Addiction Treatment Act" to the broader "Restoring Hope for Mental Health
SHM supports the reintroduction of the Mainstreaming Addiction Treatment Act. This legislation will eliminate the X-Waiver prescribing requirement for buprenorphine, a lifesaving medication used
SHM and other stakeholders sent a letter to Congressional leaders, urging for the elimination of the X-waiver. Eliminating the X-waiver will expand access to buprenorphine, a lifesaving treatment
SHM submits comments on the HCAHPS survey pain communication questions in the 2019 Outpatient Prospective Payment System Rule.
SHM submitted comments to the Ways and Means Committee and subcommittee on health regarding the opioid epidemic.
SHM responds to the Senate Finance Committee request for feedback on policies to address the opioid epidemic.